1-10 of 10
Ying Cheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Analysis of a Phase 1 Study of Zanubrutinib Plus Lenalidomide in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Zheng Song, Ying Cheng, Haiyan Yang, Liling Zhang, Liqun Zou, Ye Guo, Junning Cao, Huiqiang Huang, Zhao Wang, Sha Huang, Yiqian Fang, Jiaoyan Lyu, Keshu Zhou, Huilai Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 986.
https://doi.org/10.1182/blood-2024-193167
Published: 2024
Journal Articles

Favorable Safety Profile and Durable Responses to Pmb-CT01 (BAFFR-CAR T Cell) Therapy in Patients with B-Cell Lymphomas Ineligible for or Who Failed CD19-Targeted Therapy, Including CD19-Negative Disease

Marissa Morales Del Real, John H. Baird, Lu Chen, Joo Y. Song, Xiuli Wang, Swetha Kambhampati, Alan Macias, Emanuela C Marcucci, Soungchul Cha, Zhenyuan Dong, Teresa Kim, Baishakhi Barva, Sandrine Puverel, Qing Liu-Michael, Hazel Ting-Ying Cheng, Stephen J. Forman, Larry W. Kwak, Lihua E. Budde
Journal: Blood
Blood (2024) 144 (Supplement 1): 3127.
https://doi.org/10.1182/blood-2024-198416
Published: 2024
Journal Articles

Mettl3-Mediated m 6 a Modification Is Essential for the Maintenance of Genomic Stability of Erythroid Cells

Linlin Zhang, Huizhi Zhao, Shihui Wang, Xueting Wu, Qianqian Yang, Ying Cheng, Jiangwei Zhao, Shijie Zhang, Huan Zhang, Lixiang Chen, Xiuli An, Xiaoli Qu
Journal: Blood
Blood (2024) 144 (Supplement 1): 2449.
https://doi.org/10.1182/blood-2024-209073
Published: 2024
Journal Articles

Promising Safety and Anti-Lymphoma Efficacy of Autologous Pmb-CT01 (BAFFRCAR T Cell) Therapy in a First-in-Human Phase 1 Study

L. Elizabeth Budde, Marissa Morales Del Real, John H. Baird, Lu Chen, Joo Y. Song, Swetha Kambhampati, Alan Macias, Teresa Kim, Sylvia Dulan, Baishakhi Barva, Sandrine Puverel, Katrin Tiemann, Hazel Ting-Ying Cheng, Stephen J. Forman, Larry W. Kwak
Journal: Blood
Blood (2023) 142 (Supplement 1): 221.
https://doi.org/10.1182/blood-2023-183032
Published: 2023
Journal Articles

EX103, a Novel CD20xCD3 Bispecific Antibody, Showed a Favorable Safety and Potent Single-Agent Antitumor Activity in Heavily Pretreated Relapsed/Refractory Patients with B-Cell Non-Hodgkin Lymphoma

Junyuan Qi, Mingyuan Sun, Keshu Zhou, Chunyan Ji, Fei Lu, Chunkang Chang, Wenjun Zhang, Daniel Yang, Jiali Lu, Jisen Li, Ying Cheng, Yanfei Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6230.
https://doi.org/10.1182/blood-2023-173486
Published: 2023
Journal Articles

Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Huilai Zhang, Keshu Zhou, Ying Cheng, Liling Zhang, Haiyan Yang, Liqun Zou, Junning Cao, Huiqiang Huang, Ye Guo, Zhao Wang, Sha Huang, Zhiyu Liang, Hui Yao, Haiyi Guo, Yiqian Fang, Hongjie Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3750–3752.
https://doi.org/10.1182/blood-2022-155979
Published: 2022
Journal Articles

YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m 6 A-dependent manner

Mengdie Feng, Xueqin Xie, Guoqiang Han, Tiantian Zhang, Yashu Li, Yicun Li, Rong Yin, Qifan Wang, Tong Zhang, Peipei Wang, Jin Hu, Ying Cheng, Zhuying Gao, Jing Wang, Jiwei Chang, Manman Cui, Kexin Gao, Jihua Chai, Weidong Liu, Chengli Guo, Shaoguang Li, Lingbo Liu, Fuling Zhou, Jianjun Chen, Haojian Zhang
Journal: Blood
Blood (2021) 138 (1): 71–85.
https://doi.org/10.1182/blood.2020009676
Published: 2021
Includes: Supplemental data
Journal Articles

Long-Term Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study

Yuqin Song, MD PhD, Yongping Song, MD, Lihong Liu, MD, Mingzhi Zhang, MD, Zhiming Li, MD PhD, Chunyan Ji, MD, Wei Xu, MD PhD, Ting Liu, MD PhD, Bing Xu, MD PhD, Xin Wang, MDPhD, Sujun Gao, Huilai Zhang, MD PhD, Yu Hu, MD, Yan Li, Ying Cheng, Haiyan Yang, MD PhD, Junning Cao, Zunmin Zhu, MD, Jianda Hu, MDPhD, Wei Zhang, Hongmei Jing, MD PhD, Kaiyang Ding, Zhengguang Lu, Bin Zhang, PhD, Renbin Zhao, PhD, Zhixin Xu, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-141781
Published: 2020
Journal Articles

Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study

Yuqin Song, MD PhD, Yongping Song, MD, Lihong Liu, Mingzhi Zhang, Zhiming Li, Chunyan Ji, Wei Xu, MD PhD, Ting Liu, MD, Bing Xu, Xin Wang, MD PhD, Sujun Gao, Huilai Zhang, MD, Yu Hu, Yan Li, Ying Cheng, Haiyan Yang, Junning Cao, MD, Zunmin Zhu, Jianda Hu, PhD, Wei Zhang, Hongmei Jing, Kaiyang Ding, Zhengguang Lu, Bin Zhang, PhD, Renbin Zhao, Zhixin Xu, Jun Zhu, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 755.
https://doi.org/10.1182/blood-2019-126305
Published: 2019
Journal Articles

LNK (SH2B3) Synergizes with TP53 in Suppressing B-Precursor Acute Lymphoblastic Leukemia through IL-7 Receptor Signaling

Ying Cheng, PhD, Kudakwashe Chikwava, MD, Chao Wu, MS, Anchit Bhagat, MS, John K. Choi, MD, Wei Tong, PhD
Journal: Blood
Blood (2014) 124 (21): 1074.
https://doi.org/10.1182/blood.V124.21.1074.1074
Published: 2014